Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Neuroendocrine Tumors 3Gastro-enteropancreatic neuroendocrine tumor 3Adenoma, Islet Cell 2Recurrence 1Pancreatitis 1Pancreatic Intraductal Neoplasms 1Meningioma 1Fistula 1Duodenal Neoplasms 1Carcinoid Tumor 1Acromegaly 1

Interventions

Pancreaticojejunostomy 2obeticholic acid 1fludarabine 1aldesleukin 1X-Rays 1Tissue Adhesives 1Tea 1Stents 1Specimen Handling 1Phantoms, Imaging 1Octreotide 1Iopamidol 1Hydromorphone 1Hydrocortisone 1High-Energy Shock Waves 1Endoscopy, Gastrointestinal 1Endoscopic Mucosal Resection 1Cyclophosphamide 1Bupivacaine 1Biopsy 1Anti-Bacterial Agents 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Duodenal Neoplasms × Octreotide × 1 year × Clear all
NCT07262957 2025-12-22

PANENCA

Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

Phase 4 Recruiting
400 enrolled
Gastrointestinal

Pancreatic Intraductal Neoplasms, Duodenal Neoplasms, Fistula, Pancreatitis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡